Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 trial evaluating TH-302 in combination with gemcitabine for previously untreated metastatic or locally advanced unresectable pancr…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma [Phase 2]
This Phase 2 trial evaluated evofosfamide (TH-302) with gemcitabine versus gemcitabine alone in patients with previously untreated pancreati…
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) [Phase 1, Phase 2]
Phase 1/2 trial evaluating TTFields at 150 kHz with gemcitabine or gemcitabine plus nab-paclitaxel for frontline advanced pancreatic adenoca…
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma [Phase 1, Phase 2]
A Phase I/II trial evaluating the investigational agent PAXG in patients with stage III–IV pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 1]
A Phase 1 study evaluating the combination of dinaciclib and MK-2206 in patients with unresectable pancreatic cancer (pancreatic adenocarcin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating the combination of 3-AP (Triapine) with radiation therapy in patients with unresectable stage III pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma [Phase 1]
This document reports the completion of a Phase 1 trial evaluating the combination of FOLFIRINOX with IPI-926 in adults with advanced pancre…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas [Phase 1, Phase 2]
Clinical trial update for pre-surgery gemcitabine plus hydroxychloroquine in stage IIb/III pancreatic adenocarcinoma (Phase 1/Phase 2) has c…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial update indicating the study of Z-360 in combination with gemcitabine for metastatic pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating gemcitabine with or without MSC1936369B in pancreatic adenocarcinoma has completed and results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies [Phase 2]
Phase 2 trial of PF-03084014 in combination with gemcitabine and nab-paclitaxel in metastatic pancreatic adenocarcinoma was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery [NA]
A completed clinical trial update evaluating slide interpretation versus standard surgical pathology for assessing surgical margin status in…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Study of MLN0264 in Patients With Pancreatic Cancer [Phase 2]
Phase 2 study of MLN0264 in pancreatic adenocarcinoma was terminated, with results posted in May 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating XELOXIRI (capecitabine, oxaliplatin, and irinotecan) as first-line therapy in patients with advanced unresectable p…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluated capecitabine plus oxaliplatin in patients with advanced or metastatic pancreatic adenocarcinoma; the study has com…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the biological effects of combining nab-paclitaxel with gemcitabine in metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Spectroscopy From Duodenum [NA]
Clinical trial update announcing the completion of a study evaluating spectroscopic analysis from the duodenum in pancreatic adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 study evaluating vaccination with poly-ICLC and autologous dendritic cells in patients with non-resectable pancreatic adenocarcino…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma
The document reports that sarcopenia is an independent prognostic factor for overall survival in patients with pancreatic adenocarcinoma. Th…
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for the NanoKnife Low Energy Direct Current (LEDC) System in locally advanced unresectable pancreatic cancer h…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating selumetinib with erlotinib in locally advanced or metastatic pancreatic cancer has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma [Phase 1]
Phase 1 trial evaluating FOLFIRINOX plus PF-04136309 in patients with borderline resectable and locally advanced pancreatic adenocarcinoma h…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer [Phase 3]
This update covers a Phase 3 trial of gemcitabine in combination with ON-01910.Na for previously untreated metastatic pancreatic adenocarcin…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: The Study of Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial investigating a treatment for metastatic pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer [EARLY_Phase 1]
An update on an early-phase Phase 1 trial evaluating pre-operative Cyberknife radiotherapy for potentially resectable pancreatic cancer.